Omega-3 polyunsaturated fatty acids and heart rate variability

Frontiers in Physiology

Volumn 2 NOV, Issue , 2011, Pages

  Christensen, Jeppe Hagstrup ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autonomic function; Heart rate variability; Omega 3 polyunsaturated fatty acids; Sudden cardiac death

Indexed keywords

EID: 84860835557     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00084     Document Type: Article

References (90)

1. Airaksinen, K. E. (1999). Autonomic mechanisms and sudden death after abrupt coronary occlusion. Ann. Med. 31, 240-245.
2. Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C., and Cohen, R. J. (1981). Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213, 220-222.
3. Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Wil-lett, W. C., and Ma, J. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113-1118.
4. Albert, C. M., Hennekens, C. H., O'Donnell, C. J., Ajani, U. A., Carey, V. J., Willett, W. C., Ruskin, J. N., and Manson, J. E. (1998). Fish consumption and risk of sudden cardiac death. JAMA 279, 23-28.
5. Barron, H. V., and Lesh, M. D. (1996). Autonomic nervous system and sudden cardiac death. J. Am. Coll. Cardiol. 27, 1053-1060.
6. Beltz, B. S., Tlusty, M. F., Benton, J. L., and Sandeman, D. C. (2007). Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett. 415, 154-158.
7. Bigger, J. T. Jr., Fleiss, J. L., Stein-man, R. C., Rolnitzky, L. M., Kleiger, R. E., and Rottman, J. N. (1992a). Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am. J. Cardiol. 69, 891-898.
8. Bigger, J. T. Jr., Fleiss, J. L., Steinman, R. C., Rolnitzky, L. M., Kleiger, R. E., and Rottman, J. N. (1992b). Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85, 164-171.
9. Billman, G. E., and Harris, W. S. (2011). Effect of dietary omega-3 fatty acids on the heart rate and the heart rate variability responses to myocardial ischemia or submaximal exercise. Am. J. Physiol. Heart Circ. Physiol. 300, H2288-H2299.
10. Billman, G. E., Schwartz, P. J., and Stone, H. L. (1982). Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 66, 874-880.
11. Brouwer, I. A., Zock, P. L., van Amelsvoort, L. G., Katan, M. B., and Schouten, E. G. (2002). Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk inhealthy volunteers. Am. J. Cardiol. 89, 629-631.
12. Carney, R. M., Freedland, K. E., Stein, P. K., Steinmeyer, B. C., Harris, W. S., Rubin, E. H., Krone, R. J., and Rich, M. W. (2010). Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease. Psychosom. Med. 72, 748-754.
13. Chandra, P., Sands, R. L., Gillespie, B. W., Levin, N. W., Kotanko, P., Kiser, M., Finkelstein, F., Hinderliter, A., Pop-Busui, R., Rajagopalan, S., and Saran, R. (2011). Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfr340
14. Christensen, J. H. (2003). n-3 Fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan. Med. Bull. 50, 347-367.
15. Christensen, J. H., Aaroe, J., Knudsen, N., Dideriksen, K., Kornerup, H. J., Dyerberg, J., and Schmidt, E. B. (1998). Heart rate variability and n-3 fatty acids in patients with chronic renal failure - a pilot study. Clin. Nephrol. 49, 102-106.
16. Christensen, J. H., Christensen, M. S., Dyerberg, J., and Schmidt, E. B. (1999). Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am. J. Clin. Nutr. 70, 331-337.
17. Christensen, J. H., Gustenhoff, P., Korup, E., Aaroe, J., Toft, E., Moller, J., Rasmussen, K., Dyerberg, J., and Schmidt, E. B. (1996). Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312, 677-678.
18. Christensen, J. H., Korup, E., Aaroe, J., Toft, E., Moller, J., Rasmussen, K., Dyerberg, J., and Schmidt, E. B. (1997). Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am. J. Cardiol. 79, 1670-1673.
19. Christensen, J. H., Skou, H. A., Fog, L., Hansen, V., Vesterlund, T., Dyerberg, J., Toft, E., and Schmidt, E. B. (2001a). Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103, 651-657.
20. Christensen, J. H., Skou, H. A., Mad-sen, T., Torring, I., and Schmidt, E. B. (2001b). Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J. Intern. Med. 249, 545-552.
21. DeGiorgio, C. M., Miller, P., Meymandi, S., and Gornbein, J. A. (2008). n-3 Fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav. 13, 681-684.
22. Dekker, J. M., Schouten, E. G., Klootwijk, P., Pool, J., Swenne, C. A., and Kromhout, D. (1997). Heart rate variability from short electrocardio-graphic recordings predicts mortality from all causes in middle-aged and elderly men. The Zut-phen Study. Am. J. Epidemiol. 145, 899-908. [See comments]
23. Denver, J. W., Reed, S. F., and Porges, S. W. (2007). Methodological issues in the quantification of respiratory sinus arrhythmia. Biol. Psychol. 74, 286-294.
24. Dyerberg, J., Eskesen, D. C., Andersen, P. W., Astrup, A., Buemann, B., Chris-tensen, J. H., Clausen, P., Rasmussen, B. F., Schmidt, E. B., Tholstrup, T., Toft, E., Toubro, S., and Stender, S. (2004). Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur. J. Clin. Nutr. 58, 1062-1070.
25. Eckberg, D. L. (1997). Sympathovagal balance: a critical appraisal. Circulation 96, 3224-3232.
26. Eslick, G. D., Howe, P. R., Smith, C., Priest,R.,and Bensoussan,A. (2009). Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int. J. Cardiol. 136, 4-16.
27. Fassett, R. G., Gobe, G. C., Peake, J. M., and Coombes, J. S. (2010). Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am. J. Kidney Dis. 56, 728-742.
28. Fiedler, R., Mall, M., Wand, C., and Osten, B. (2005). Shortterm administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J. Ren. Nutr. 15, 253-256.
29. Friedman, A., and Moe, S. (2006). Review of the effects of omega-3 supplementation in dialysis patients. Clin. J. Am. Soc. Nephrol. 1, 182-192.
30. Furlan, R., Guzzetti, S., Crivellaro, W., Dassi, S., Tinelli, M., Baselli, G., Cerutti, S., Lombardi, F., Pagani, M., and Malliani, A. (1990). Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 81, 537-547.
31. Geelen, A., Zock, P. L., Swenne, C. A., Brouwer, I. A., Schouten, E. G., and Katan, M. B. (2003). Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am. Heart J. 146, E4.
32. Grimsgaard, S., Bonaa, K. H., Hansen, J. B., and Myhre, E. S. (1998). Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am. J. Clin. Nutr. 68, 52-59.
33. Hamaad, A., Kaeng, L. W., Lip, G. Y., and MacFadyen, R. J. (2006). Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc. Drugs Ther. 20, 359-364.
34. Hansen, A. L., Dahl, L., Bakke, L., Frøy-land, L., and Thayer, J. F. (2010). Fish consumption and heart rate variability - preliminary results. J. Psychophysiol. 24, 41-47.
35. Harris, W. S., Gonzales, M., Laney, N., Sastre, A., and Borkon, A. M. (2006). Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am. J. Cardiol. 98, 1393-1395.
36. Hayano, J., Takahashi, H., Toriyama, T., Mukai, S., Okada, A., Sakata, S., Yamada, A., Ohte, N., and Kawahara, H. (1999). Prognostic value of heart rate variability during longterm follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol. Dial. Transplant. 14, 1480-1488.
37. Herzog, C. A., Mangrum, J. M., and Passman, R. (2008). Sudden cardiac death and dialysis patients. Semin. Dial. 21, 300-307.
38. Holguin, F., Tellez-Rojo, M. M., Lazo, M., Mannino, D., Schwartz, J., Hernandez, M., and Romieu, I. (2005). Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127, 1102-1107.
39. Innis, S. M. (2008). Dietary omega 3 fatty acids and the developing brain. Brain Res. 1237, 35-43.
40. Kannel, W. B., and McGee, D. L. (1979). Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035-2038.
41. Karemaker, J. M. (1999). Autonomic integration: the physiological basis of cardiovascular variability. J. Physiol. 517, 316.
42. Kim, S. H., Kim, M. K., Lee, H. Y., Kang, H. J., Kim, Y. J., and Kim, H. S. (2011). Prospective randomized comparison between omega-3 fatty acid supplements plus sim-vastatin versus simvastatin alone in Korean patients with mixed dyslipi-demia: lipoprotein profiles and heartate variability. Eur. J. Clin. Nutr. 65, 110-116.
43. Kingwell, B. A., Thompson, J. M., Kaye, D. M., McPherson, G. A., Jennings, G. L., and Esler, M. D. (1994). Heart rate spectral analysis, cardiac nor-epinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 90, 234-240.
44. Kleiger, R. E., Bigger, J. T., Bosner, M. S., Chung, M. K., Cook, J. R., Rolnitzky, L. M., Steinman, R., and Fleiss, J. L. (1991). Stability over time of variables measuring heart rate variabil-ityinnormal subjects. Am. J. Cardiol. 68, 626-630.
45. Kleiger, R. E., Stein, P. K., and Bigger, J. T. Jr. (2005). Heart rate variability: measurement and clinical utility. Ann. Noninvasive Electrocardiol. 10, 88-101.
46. Kleiger, R. E., Stein, P. K., Bosner, M. S., and Rottman, J. N. (1992). Time domain measurements of heart rate variability. Cardiol. Clin. 10, 487-498.
47. La Rovere, M. T., Bigger, J. T. Jr., Marcus, F. I., Mortara, A., and Schwartz, P. J. (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) Investigators. Lancet 351, 478-484.
48. Larnkjaer, A., Christensen, J. H., Michaelsen, K. F., and Lauritzen, L. (2006). Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5-y-old children. J. Nutr. 136, 1539-1544.
49. Lauritzen, L., Christensen, J. H., Dams-gaard, C. T., and Michaelsen, K. F. (2008). The effect of fish oil supplementation on heart rate in healthy Danish infants. Pediatr. Res. 64, 610-614.
50. Madsen, T., Christensen, J. H., Svensson, M., Witt, P. M., Toft, E., and Schmidt, E.B.(2011). Marinen-3polyunsatu-rated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study. J. Ren. Nutr. 21, 169-175.
51. Mak, K. H., and Topol, E. J. (2000). Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J. Am. Coll. Cardiol. 35, 563-568.
52. Maser, R. E., and Lenhard, M. J. (2005). Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J. Clin. Endocrinol. Metab. 90, 5896-5903.
53. Massin, M., and von Bernuth, G. (1997). Normal ranges of heart rate variability during infancy and childhood. Pediatr. Cardiol. 18, 297-302.
54. Molgaard, H., Sorensen, K. E., and Bjer-regaard, P. (1991). Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin. Auton. Res. 1, 233-237.
55. Mozaffarian, D., Geelen, A., Brouwer, I. A., Geleijnse, J. M., Zock, P. L., and Katan, M. B. (2005). Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112, 1945-1952.
56. Mozaffarian, D., Stein, P. K., Prineas, R. J., and Siscovick, D. S. (2008). Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 117, 1130-1137.
57. Murray, D. R. (2003). What is "heart rate variability" and is it blunted by tumor necrosis factor? Chest 123, 664-667.
58. Niemoller, T. D., and Bazan, N. G. (2010). Docosahexaenoic acid neu-rolipidomics. Prostaglandins Other Lipid Mediat. 91, 85-89.
59. Ninio, D. M., Hill, A. M., Howe, P. R., Buckley,J. D., and Saint, D. A. (2008). Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. Br. J. Nutr. 100, 1097-1103.
60. Nodari, S., Metra, M., Milesi, G., Manerba, A., Cesana, B. M., Gheo-rghiade, M., and Dei, C. L. (2009). The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc. Drugs Ther. 23, 5-15.
61. Oikawa, K., Ishihara, R., Maeda, T.,Yam-aguchi, K., Koike, A., Kawaguchi, H., Tabata, Y., and Itoh, H. (2009). Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int. J. Cardiol. 131, 370-377.
62. O'Keefe, J. H. Jr., Abuissa, H., Sastre, A., Steinhaus, D. M., and Harris, W. S. (2006). Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am. J. Cardiol. 97, 1127-1130.
63. Pagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P., Sandrone, G., Malfatto, G., Dell'Orto, S., and Piccaluga, E. (1986). Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ. Res. 59, 178-193.
64. Pagani, M., Malfatto, G., Pierini, S., Casati, R., Masu, A. M., Poli, M., Guzzetti, S., Lombardi, F., Cerutti, S., and Malliani, A. (1988). Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J. Auton. Nerv. Syst. 23, 143-153.
65. Palatini, P., and Julius, S. (2004). Elevated heart rate: a major risk factor for cardiovascular disease. Clin. Exp. Hypertens. 26, 637-644.
66. Parati, G., Mancia, G., Di, R. M., and Castiglioni, P. (2006). Point: cardiovascular variability is/is not an index of autonomic control of circulation. J. Appl. Physiol. 101, 676-678.
67. Park, S. K., Tucker, K. L., O'Neill, M. S., Sparrow, D., Vokonas, P. S., Hu, H., and Schwartz, J. (2009). Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study. Am. J. Clin. Nutr. 89, 778-786.
68. Pivik, R. T., and Dykman, R. A. (2004). Cardiovascular effects of morning nutrition in preadolescents. Physiol. Behav. 82, 295-302.
69. Pivik, R. T., Dykman, R. A., Jing, H., Gilchrist, J. M., and Badger, T. M. (2009). Early infant diet and the omega 3 fatty acid DHA: effects on resting cardiovascular activity and behavioral development during the first half-year of life. Dev. Neuropsy-chol. 34, 139-158.
70. Pomeranz, B., Macaulay, R. J., Caudill, M. A., Kutz, I.,Adam, D., Gordon, D., Kilborn, K. M., Barger, A. C., Shannon, D. C., Cohen, R. J., and Benson, H. (1985). Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 248, H151-H153.
71. Romieu, I., Tellez-Rojo, M. M., Lazo, M., Manzano-Patino, A., Cortez-Lugo, M., Julien, P., Belanger, M. C., Hernandez-Avila, M., and Holguin, F. (2005). Omega-3 fatty acid prevents heart rate variability reductions associated with particulatematter. Am. J. Respir. Crit. Care Med. 172, 1534-1540.
72. Russo, C., Olivieri, O., Girelli, D., Azz-ini, M., Stanzial, A. M., Guarini, P., Friso, S., De, F. L., and Corrocher, R. (1995). Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension. J. Hypertens. 13, 1823-1826.
73. Santini, V., Ciampittiello, G., Gigli, F., Bracaglia, D., Baroni, A., Cic-conetti, E., Verri, C., Gambardella, S., and Frontoni, S. (2007). QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA. Nutr. Metab. Cardiovasc. Dis. 17, 712-718.
74. Schwartz, P. J. (1998). The autonomic nervous system and sudden death. Eur. Heart J. 19(Suppl. F), F72-F80.
75. Schwartz, P. J., Billman, G. E., and Stone, H. L. (1984). Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 69, 790-800.
76. Schwartz, P. J., LA Rovere, M. T., and Vanoli, E. (1992). Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85, 177-191.
77. Siscovick, D. S., Raghunathan, T., King, I., Weinmann, S., Bovbjerg, V. E., Kushi, L., Cobb, L. A., Copass, M. K., Psaty, B. M., Lemaitre, R., Retzlaff, B., and Knopp, R. H. (2000). Dietary intake of longchain n-3 polyunsat-urated fatty acids and the risk of primary cardiac arrest. Am. J. Clin. Nutr. 71, 208S-212S.
78. Siscovick, D. S., Raghunathan, T. E., King, I., Weinmann, S., Wicklund, K. G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., Kushi, L. H., Cobb, L. A., Copass, M. K., Psaty, B. M., Lemaitre, R., Ret-zlaff, B., Childs, M., and Knopp, R.H. (1995). Dietary intake and cell membrane levels of long-chain n3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274, 1363-1367.
79. Srinivasan, K., Sucharita, S., and Vaz, M. (2002). Effect of standing on short term heart rate variability across age. Clin. Physiol. Funct. Imaging 22, 404-408.
80. Stein, P. K., and Kleiger, R. E. (1999). Insights from the study of heart rate variability. Annu. Rev. Med. 50, 249-261.
81. Svensson, M., Schmidt, E. B., Jorgensen, K. A., and Christensen, J. H. (2007). The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. J. Ren. Nutr. 17, 243-249.
82. Task Force of the European Society of Cardiology, and the North American Society of Pacing, and Electrophysiology. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93, 1043-1065.
83. Taylor, J. A., Myers, C. W., Halliwill, J. R., Seidel, H., and Eckberg, D. L. (2001). Sympathetic restraint of respiratory sinus arrhythmia: implications for vagalcardiac tone assessment in humans. Am. J. Physiol. Heart Circ. Physiol. 280, H2804- H2814.
84. Tibblin, G., Eriksson, C.-G., Bjurö, T., Georgescu, D., and Svärdsudd, C. (1975). Heart rate and heart rate variability a risk factor for the development of ischaemic heart disease (IHD) in the "men born in 1913 study" - a ten years follow-up. Med. Sci. Cardiovasc. Syst. Soc. Occup. 3, 95.
85. Tsuji, H., Larson, M. G.,Venditti, F. J. Jr., Manders, E. S., Evans, J. C., Feldman, C. L., and Levy, D. (1996). Impact of reduced heart rate variability on risk for cardiac events. The Fram-ingham Heart Study. Circulation 94, 2850-2855.
86. Tsuji, H.,Venditti, F. J. Jr., Manders, E. S., Evans, J. C., Larson, M. G., Feldman,C. L., and Levy, D. (1994). Reduced heart rate variability and mortality risk in an elderly cohort. The Fram-ingham Heart Study. Circulation 90, 878-883.
87. Valera, B., Dewailly, E., Nassour-Laouan-Sidi, E., and Poirier, P. (2011). Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults. Int. J. Circumpolar Health 70, 6-18.
88. Verkerk, A. O., den Ruijter, H. M., Bourier, J., Boukens, B. J., Brouwer, I. A., Wilders, R., and Coronel, R. (2009). Dietary fish oil reduces pacemaker current and heart rate in rabbit. Heart Rhythm. 6, 1485-1492.
89. Villa, B., Calabresi, L., Chiesa, G., Rise, P., Galli, C., and Sirtori, C. R. (2002). Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol. Res. 45, 475.
90. Zipes, D. P., and Wellens, H. J. (1998). Sudden cardiac death. Circulation 98, 2334-2351.